Opportunity Information: Apply for PAR 21 112
The NIH grant opportunity titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)" (Funding Opportunity Number PAR-21-112) is a discretionary grant designed to strengthen the workforce needed to move Alzheimer's and related dementias research from early scientific ideas to real-world clinical advances. The central goal is workforce development: building a diverse, highly trained, interdisciplinary pipeline of researchers who can work across the full translational spectrum, from target discovery and preclinical studies through clinical development.
This FOA specifically supports institutional T32 training programs, meaning the funding goes to organizations that will run structured training environments rather than to individual trainees. These programs are intended to support both predoctoral and postdoctoral researchers, recognizing that translational Alzheimer's research needs talent at multiple career stages. A key feature is that trainees can come from varied educational and technical backgrounds, including basic biology and neuroscience, translational and clinical research, and data science. The expectation is that participating institutions will intentionally blend these perspectives into a coherent program so trainees learn to communicate and collaborate across disciplines, which is often essential in drug discovery, biomarker development, and clinical translation.
Programmatically, NIH is looking for institutions to propose training that equips participants with practical and conceptual skills spanning data science, disease biology, behavioral research, and both traditional and emerging drug discovery disciplines. In practice, this signals an interest in training plans that go beyond classical bench science alone and include exposure to modern analytics (for example, computational methods and complex datasets), the biological underpinnings of AD/ADRD, and the behavioral and clinical dimensions that shape how dementia is studied and treated in real populations. The emphasis on "rigorous and cutting-edge basic, translational, and clinical research" suggests NIH expects strong mentorship, well-defined curricula or training activities, and an environment that prepares trainees to contribute to therapeutics development and related translational outcomes.
Eligibility is broad and includes many types of domestic organizations that can administer NIH training grants. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations (including those other than federally recognized governments); public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other categories as allowed by NIH. The FOA also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), regional organizations, and eligible federal agencies. This emphasis aligns with the stated goal of developing a diverse workforce and encourages applications from institutions that serve historically underrepresented or underserved communities.
At the same time, there are clear restrictions related to foreign involvement. Non-domestic (non-U.S.) entities, including foreign organizations and foreign institutions, are not eligible to apply. In addition, non-domestic components of U.S. organizations are not eligible to apply under this announcement. In other words, the applicant organization and the supported institutional training program must be domestic, and the program cannot be run through an overseas component of a U.S.-based institution.
Administrative details provided in the source information include that the sponsoring agency is the National Institutes of Health (NIH), the CFDA (now commonly referred to under assistance listings) number is 93.866, the opportunity was created on 2021-01-22, and the original closing date listed is 2023-09-25. The funding instrument type is a grant, and the activity category is health. An award ceiling is not specified in the provided data, and the expected number of awards is not listed. Overall, the opportunity is best understood as NIH support for institutions to build or strengthen structured, interdisciplinary AD/ADRD translational training programs that produce researchers capable of bridging discovery science, data-driven approaches, and clinical development.Apply for PAR 21 112
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2021-01-22.
- Applicants must submit their applications by 2023-09-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Central Valley Project Conservation Program for Fiscal Year 2021 and 2022
Previous opportunity: Announcement for Program Funding for NRCS’s Regional Conservation Partnership Program (RCPP) for Federal Fiscal Years (FYs) 2020 and 2021.
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 21 112
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 21 112) also looked into and applied for these:
| Funding Opportunity |
|---|
| Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 21 006 Funding Number: RFA RM 21 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nutrition for Precision Health, powered by the All of Us Research Program: Microbiome and Metagenomics Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 21 003 Funding Number: RFA RM 21 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nutrition for Precision Health, powered by the All of Us Research Program: Artificial Intelligence for Multimodal Data Modeling and Bioinformatics Center (U54 Clinical Trial Not Allowed) Apply for RFA RM 21 001 Funding Number: RFA RM 21 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) Apply for PAR 21 106 Funding Number: PAR 21 106 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed) Apply for PAR 21 114 Funding Number: PAR 21 114 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed) Apply for PAR 20 317 Funding Number: PAR 20 317 Agency: National Institutes of Health Category: Health Funding Amount: $375,000 |
| The Cellular Scale Connectome in Aging and Alzheimers Disease (U01 Clinical Trial Not Allowed) Apply for RFA AG 22 008 Funding Number: RFA AG 22 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition for the Continuation of Multisite Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Optional) Apply for PAR 21 116 Funding Number: PAR 21 116 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Limited Competition for the Continuation or Revision of Multisite Clinical Trial Clinical Coordinating Center (Collaborative UH3 Clinical Trial Optional) Apply for PAR 21 117 Funding Number: PAR 21 117 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional) Apply for PA 21 158 Funding Number: PA 21 158 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional) Apply for RFA TR 21 009 Funding Number: RFA TR 21 009 Agency: National Institutes of Health Category: Health Funding Amount: $650,000 |
| Early-Phase Clinical Trials of Novel Interventions to Prevent, Delay, or Treat Aging-Related Conditions by Targeting Aging-Related Mechanisms (U01 Clinical Trial Required) Apply for RFA AG 22 011 Funding Number: RFA AG 22 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) Apply for RFA AA 21 002 Funding Number: RFA AA 21 002 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) Apply for RFA AA 21 004 Funding Number: RFA AA 21 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) Apply for RFA AA 21 003 Funding Number: RFA AA 21 003 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed) Apply for RFA RM 21 011 Funding Number: RFA RM 21 011 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| NIDCR Predoctoral to Postdoctoral Transition Award for a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed) Apply for PAR 21 060 Funding Number: PAR 21 060 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed) Apply for PAR 21 125 Funding Number: PAR 21 125 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Human Immunology Project Consortium (U19 Clinical Trial Optional) Apply for RFA AI 20 079 Funding Number: RFA AI 20 079 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional) Apply for PA 21 164 Funding Number: PA 21 164 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 112", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
